What is the purpose of measuring serum tryptase?

Purpose of Measuring Serum Tryptase

Serum tryptase measurement serves three primary clinical purposes: confirming the diagnosis of anaphylaxis and mast cell-mediated acute reactions, diagnosing systemic mastocytosis and other clonal mast cell disorders, and identifying hereditary α-tryptasemia as a risk factor for severe reactions. 1, 2, 3

Primary Clinical Indications

1. Diagnosis of Anaphylaxis and Acute Mast Cell Activation

Tryptase is the most specific biomarker for confirming mast cell degranulation during suspected anaphylactic events. 4

• Optimal timing: Draw serum tryptase 1-2 hours after symptom onset when levels peak, though samples remain useful up to 4-6 hours post-event 1, 5
• Diagnostic formula: Peak tryptase is considered elevated when it exceeds baseline × 1.2 + 2 ng/mL (91% specificity for acute mast cell activation) 5, 6
• Serial sampling protocol: Obtain three samples—during/immediately after the event, at 1-2 hours (peak), and at 24 hours or later (baseline)—to calculate the diagnostic rise 5

Critical caveat: A normal tryptase level does not exclude anaphylaxis, as basophil-mediated or complement-mediated reactions occur without mast cell tryptase release 4, 5. The assay has high specificity but relatively low sensitivity, missing some true anaphylactic cases 4.

2. Diagnosis of Systemic Mastocytosis

Persistently elevated baseline serum tryptase >20 ng/mL is a minor diagnostic criterion for systemic mastocytosis. 2

• Mechanism: Elevated baseline reflects increased mast cell burden producing constitutive α-tryptase secretion 1
• Tryptase ratio method: Distinguishes mastocytosis from isolated anaphylaxis:
  • Ratio ≤10 (total/β-tryptase): isolated anaphylaxis without mastocytosis 1, 5
  • Ratio ≥20: consistent with systemic mastocytosis 1, 5
• Bone marrow evaluation: Required to confirm diagnosis when baseline tryptase is persistently elevated in symptomatic patients 2

3. Screening for Hereditary α-Tryptasemia (HαT)

Tryptase genotyping should be considered in symptomatic individuals with baseline serum tryptase >6.5 ng/mL to screen for HαT, which affects 4-8% of the general population and increases risk of severe reactions. 3, 7

• Clinical impact: HαT presence affects interpretation of what constitutes an "abnormal" tryptase level and influences the magnitude of rise needed to diagnose anaphylaxis 3, 7
• Genetic basis: Increased germline TPSAB1 gene copy number encoding α-tryptase 3

Differential Diagnosis Applications

Tryptase measurement helps distinguish anaphylaxis from conditions that mimic it: 1

• Scombroid poisoning: Normal tryptase levels despite histamine-mediated symptoms from spoiled fish 1
• Pheochromocytoma: Requires plasma-free metanephrine or urinary vanillylmandelic acid for diagnosis 1
• Carcinoid syndrome: Requires serum serotonin or urinary 5-hydroxyindoleacetic acid 1
• Vasoactive intestinal polypeptide-secreting tumors: Requires hormonal polypeptide panel 1

Mast Cell Activation Syndrome (MCAS) Diagnosis

All three criteria must be met for MCAS diagnosis: 8, 5

1. Recurrent systemic symptoms involving ≥2 organ systems 8
2. Tryptase rise >20% + 2 ng/mL within 1-4 hours of symptom onset 5
3. Positive clinical response to antimediator therapy 5

Critical Interpretation Pitfalls

Timing Errors

• Too early (<15 minutes): May miss the peak 5
• Too late (>6 hours): Levels return toward baseline, missing diagnostic window 1, 5
• Half-life consideration: Tryptase has a ~2-hour half-life, causing rapid decline after peak 4, 5

Confounding Factors

• IV fluid resuscitation: Dilutes blood and artificially lowers measured tryptase; must be factored into interpretation 4, 5
• False elevations: Can occur in chronic kidney disease, obesity, hematologic neoplasms, trauma, myocardial infarction, and postmortem samples 4, 5
• Inter-individual variability: Change from baseline is more diagnostically reliable than absolute values 4, 5

Forms of Tryptase

• α-tryptase: Secreted constitutively; elevated in mastocytosis 1
• β-tryptase: Released only during degranulation; rises in both anaphylaxis and mastocytosis during acute events 1

Complementary Biomarkers When Tryptase Is Equivocal

Alternative mediators provide diagnostic support when tryptase results are inconclusive: 1, 8, 5

• Plasma histamine: Peaks at 5-10 minutes, elevated for 30-60 minutes; useful only if drawn very early 1
• 24-hour urinary histamine metabolites: Elevated up to 24 hours, providing longer diagnostic window 1
• Urinary LTE₄ (leukotriene E₄): Peaks within 0-3 hours, useful up to 6 hours 8, 5
• 11β-PGF₂α: Correlates with anaphylaxis severity 8, 5

Postmortem Considerations

Elevated postmortem tryptase is not specific for anaphylactic death and cannot be considered diagnostic alone. 1

• Postmortem tryptase elevation occurs in nonanaphylactic deaths including trauma and myocardial infarction 4
• Circulation cessation prevents tryptase removal, leading to accumulation 4
• Lower predictive value compared to samples taken during life 4